Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of activation of Janus kinase activity (GO:0010533) | 5.76846846 |
2 | positive regulation of interferon-alpha production (GO:0032727) | 5.33911351 |
3 | regulation of T-helper 1 cell differentiation (GO:0045625) | 5.26413978 |
4 | neutrophil activation involved in immune response (GO:0002283) | 5.11207066 |
5 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.06401570 |
6 | regulation of interferon-alpha production (GO:0032647) | 5.02700938 |
7 | cellular response to type I interferon (GO:0071357) | 4.95552208 |
8 | type I interferon signaling pathway (GO:0060337) | 4.95552208 |
9 | T-helper 1 type immune response (GO:0042088) | 4.94845938 |
10 | response to type I interferon (GO:0034340) | 4.89884837 |
11 | positive regulation of type 2 immune response (GO:0002830) | 4.87998367 |
12 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.72477961 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.70403221 |
14 | response to peptidoglycan (GO:0032494) | 4.67874710 |
15 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 4.67650758 |
16 | negative regulation of interleukin-12 production (GO:0032695) | 4.60700648 |
17 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.48073164 |
18 | natural killer cell mediated immunity (GO:0002228) | 4.48073164 |
19 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.45785825 |
20 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.45563706 |
21 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.41646173 |
22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.39294240 |
23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.39294240 |
24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.39294240 |
25 | modulation by symbiont of host immune response (GO:0052553) | 4.39294240 |
26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.39294240 |
27 | modulation by symbiont of host defense response (GO:0052031) | 4.39294240 |
28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.39160264 |
29 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.27540508 |
30 | positive regulation of T-helper cell differentiation (GO:0045624) | 4.25715363 |
31 | NIK/NF-kappaB signaling (GO:0038061) | 4.19211886 |
32 | negative regulation of viral genome replication (GO:0045071) | 4.16743268 |
33 | regulation of RIG-I signaling pathway (GO:0039535) | 4.16734358 |
34 | granulocyte activation (GO:0036230) | 4.14287710 |
35 | neutrophil activation (GO:0042119) | 4.13118455 |
36 | * positive regulation of interleukin-12 production (GO:0032735) | 4.06253070 |
37 | regulation of vitamin metabolic process (GO:0030656) | 4.05951545 |
38 | immunoglobulin mediated immune response (GO:0016064) | 4.02936214 |
39 | positive regulation of antigen processing and presentation (GO:0002579) | 4.02875629 |
40 | cellular response to interferon-alpha (GO:0035457) | 4.01789571 |
41 | cellular response to interferon-beta (GO:0035458) | 3.99524329 |
42 | positive regulation of interleukin-17 production (GO:0032740) | 3.93719589 |
43 | response to interferon-alpha (GO:0035455) | 3.91818451 |
44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.91573789 |
45 | response to muramyl dipeptide (GO:0032495) | 3.89971718 |
46 | cellular response to virus (GO:0098586) | 3.88987925 |
47 | myeloid dendritic cell differentiation (GO:0043011) | 3.87272700 |
48 | defense response to protozoan (GO:0042832) | 3.86756596 |
49 | cellular response to exogenous dsRNA (GO:0071360) | 3.86618736 |
50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.84684862 |
51 | negative regulation of interleukin-17 production (GO:0032700) | 3.81705090 |
52 | positive regulation of interferon-beta production (GO:0032728) | 3.80923661 |
53 | germinal center formation (GO:0002467) | 3.78076772 |
54 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.77931942 |
55 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.77914759 |
56 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.76826494 |
57 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.76263520 |
58 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.74470846 |
59 | regulation of T-helper cell differentiation (GO:0045622) | 3.72641240 |
60 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.68237709 |
61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.64950345 |
62 | regulation of podosome assembly (GO:0071801) | 3.64144142 |
63 | regulation of memory T cell differentiation (GO:0043380) | 3.62255687 |
64 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.59246645 |
65 | cellular response to zinc ion (GO:0071294) | 3.57205977 |
66 | positive regulation of T cell cytokine production (GO:0002726) | 3.55758439 |
67 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.54905230 |
68 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.54044556 |
69 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.53354828 |
70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52291326 |
71 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.52291326 |
72 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.51628763 |
73 | dendritic cell differentiation (GO:0097028) | 3.51016906 |
74 | positive regulation of heat generation (GO:0031652) | 3.50111967 |
75 | regulation of antigen processing and presentation (GO:0002577) | 3.46204967 |
76 | myeloid dendritic cell activation (GO:0001773) | 3.46173546 |
77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.46108294 |
78 | regulation of fever generation (GO:0031620) | 3.45306339 |
79 | respiratory burst (GO:0045730) | 3.41756538 |
80 | monocyte chemotaxis (GO:0002548) | 3.39738986 |
81 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.39572751 |
82 | regulation of interleukin-17 production (GO:0032660) | 3.39305370 |
83 | macrophage activation involved in immune response (GO:0002281) | 3.39028590 |
84 | response to interferon-beta (GO:0035456) | 3.38549036 |
85 | positive regulation of response to biotic stimulus (GO:0002833) | 3.36937604 |
86 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.36820857 |
87 | regulation of T-helper 1 type immune response (GO:0002825) | 3.36711007 |
88 | superoxide anion generation (GO:0042554) | 3.36252783 |
89 | response to interferon-gamma (GO:0034341) | 3.34908710 |
90 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.34463488 |
91 | eosinophil chemotaxis (GO:0048245) | 3.32975312 |
92 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.31381615 |
93 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.29401822 |
94 | leukocyte mediated cytotoxicity (GO:0001909) | 3.29100295 |
95 | B cell mediated immunity (GO:0019724) | 3.28912331 |
96 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.28828951 |
97 | cellular response to interferon-gamma (GO:0071346) | 3.26889420 |
98 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.26223440 |
99 | positive regulation of defense response to virus by host (GO:0002230) | 3.25681530 |
100 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.23566649 |
101 | response to protozoan (GO:0001562) | 3.22257924 |
102 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21121483 |
103 | response to host immune response (GO:0052572) | 3.21121483 |
104 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.20675752 |
105 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.17236419 |
106 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.16575083 |
107 | reactive oxygen species biosynthetic process (GO:1903409) | 3.16015205 |
108 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.15744512 |
109 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.15687284 |
110 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.15067877 |
111 | T cell migration (GO:0072678) | 3.14765188 |
112 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.14446410 |
113 | * regulation of interleukin-12 production (GO:0032655) | 3.13764411 |
114 | regulation of chemokine biosynthetic process (GO:0045073) | 3.13608989 |
115 | regulation of mononuclear cell migration (GO:0071675) | 3.12201967 |
116 | lymphocyte chemotaxis (GO:0048247) | 3.11262958 |
117 | activation of MAPKKK activity (GO:0000185) | 3.11074237 |
118 | positive regulation of interleukin-10 production (GO:0032733) | 3.10667207 |
119 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.08565887 |
120 | regulation of defense response to virus by host (GO:0050691) | 3.08543952 |
121 | regulation of chronic inflammatory response (GO:0002676) | 3.07364748 |
122 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.03850055 |
123 | detection of other organism (GO:0098543) | 3.00301871 |
124 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.00220983 |
125 | regulation of type 2 immune response (GO:0002828) | 2.99240909 |
126 | detection of bacterium (GO:0016045) | 2.98143977 |
127 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.96608472 |
128 | negative regulation of cell killing (GO:0031342) | 2.96608472 |
129 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.95985166 |
130 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.87436577 |
131 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.85775065 |
132 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.85197650 |
133 | mature B cell differentiation involved in immune response (GO:0002313) | 2.84812858 |
134 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.84796747 |
135 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.84477679 |
136 | regulation of T cell tolerance induction (GO:0002664) | 2.84259431 |
137 | * cellular response to lipopolysaccharide (GO:0071222) | 2.83628715 |
138 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.82114685 |
139 | regulation of growth of symbiont in host (GO:0044126) | 2.82114685 |
140 | negative regulation of growth of symbiont in host (GO:0044130) | 2.82114685 |
141 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.82114685 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.88323597 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.72143630 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 6.29221953 |
4 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.60073479 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.14694368 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.68677486 |
7 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.32433606 |
8 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.63598023 |
9 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56799284 |
10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.27551354 |
11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.11988060 |
12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.05771094 |
13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.95931350 |
14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.95768389 |
15 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.87706242 |
16 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.69034860 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44054922 |
18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30707822 |
19 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.13599194 |
20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08207780 |
21 | MYC_22102868_ChIP-Seq_BL_Human | 1.92180747 |
22 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81880296 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73923080 |
24 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.69701299 |
25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62664580 |
26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.60754390 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58384011 |
28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57392649 |
29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.57200744 |
30 | MYB_26560356_Chip-Seq_TH2_Human | 1.55546508 |
31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54091284 |
32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53201393 |
33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.48692214 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48091804 |
35 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47833101 |
36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46335985 |
37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43871718 |
38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.41592117 |
39 | MAF_26560356_Chip-Seq_TH1_Human | 1.31947156 |
40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31033737 |
41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30467591 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30161525 |
43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29937868 |
44 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27578623 |
45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25927084 |
46 | MYB_26560356_Chip-Seq_TH1_Human | 1.25765195 |
47 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20411898 |
48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19971590 |
49 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19562143 |
50 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18376402 |
51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.16675765 |
52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15210002 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.13916779 |
54 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10853861 |
55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.08497149 |
56 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08425248 |
57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.06143289 |
58 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05769524 |
59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04016052 |
60 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.03454032 |
61 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02541865 |
62 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99466476 |
63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98687855 |
64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98421999 |
65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97443889 |
66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96688706 |
67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96286991 |
68 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.94352967 |
69 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93054712 |
70 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92434683 |
71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92285755 |
72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91856383 |
73 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91757098 |
74 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90168402 |
75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89810109 |
76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.89330687 |
77 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.89330687 |
78 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88488981 |
79 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.88456016 |
80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86750220 |
81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86691292 |
82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84141812 |
83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83976325 |
84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83453540 |
85 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83369408 |
86 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82864419 |
87 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82586852 |
88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.82513647 |
89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82402014 |
90 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82078521 |
91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.82028132 |
92 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.81607306 |
93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81050517 |
94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.80861173 |
95 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78776880 |
96 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78289941 |
97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78145599 |
98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77941605 |
99 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76962292 |
100 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76496591 |
101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.74783258 |
102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.74734073 |
103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.73811828 |
104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.73002704 |
105 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72467922 |
106 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72467922 |
107 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72240192 |
108 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.66691649 |
109 | MAF_26560356_Chip-Seq_TH2_Human | 0.65443619 |
110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.64244688 |
111 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.63764734 |
112 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62951947 |
113 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.60189965 |
114 | CJUN_26792858_Chip-Seq_BT549_Human | 0.58489837 |
115 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.56825781 |
116 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.56568831 |
117 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.56474783 |
118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.54429630 |
119 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.53617215 |
120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.53270078 |
121 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52174395 |
122 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.51370258 |
123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.51323878 |
124 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.51116243 |
125 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.50481038 |
126 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.47916392 |
127 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.47910463 |
128 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.46984924 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 5.42612048 |
2 | MP0009785_altered_susceptibility_to | 4.54186272 |
3 | * MP0002148_abnormal_hypersensitivity_rea | 4.14086212 |
4 | MP0000685_abnormal_immune_system | 3.86039012 |
5 | MP0003436_decreased_susceptibility_to | 3.56095614 |
6 | MP0001790_abnormal_immune_system | 3.55226250 |
7 | MP0005387_immune_system_phenotype | 3.55226250 |
8 | MP0005000_abnormal_immune_tolerance | 3.42780756 |
9 | MP0006082_CNS_inflammation | 3.28366617 |
10 | MP0004510_myositis | 3.22667619 |
11 | MP0005025_abnormal_response_to | 3.19285830 |
12 | MP0002419_abnormal_innate_immunity | 2.97687236 |
13 | MP0003724_increased_susceptibility_to | 2.87757794 |
14 | * MP0005671_abnormal_response_to | 2.84652823 |
15 | MP0002452_abnormal_antigen_presenting | 2.81715813 |
16 | MP0003303_peritoneal_inflammation | 2.79698756 |
17 | * MP0001800_abnormal_humoral_immune | 2.78391732 |
18 | * MP0002723_abnormal_immune_serum | 2.69990387 |
19 | MP0003300_gastrointestinal_ulcer | 2.51186085 |
20 | MP0002139_abnormal_hepatobiliary_system | 2.42555717 |
21 | * MP0001819_abnormal_immune_cell | 2.33785600 |
22 | MP0002420_abnormal_adaptive_immunity | 2.29442605 |
23 | MP0005451_abnormal_body_composition | 2.12934295 |
24 | MP0009764_decreased_sensitivity_to | 2.11720083 |
25 | MP0002163_abnormal_gland_morphology | 2.08710570 |
26 | MP0001853_heart_inflammation | 2.05871834 |
27 | MP0005310_abnormal_salivary_gland | 2.05000905 |
28 | MP0001348_abnormal_lacrimal_gland | 1.98610794 |
29 | MP0002006_tumorigenesis | 1.97284305 |
30 | MP0004947_skin_inflammation | 1.95670874 |
31 | MP0001533_abnormal_skeleton_physiology | 1.85671125 |
32 | * MP0001845_abnormal_inflammatory_respons | 1.81126626 |
33 | MP0002405_respiratory_system_inflammati | 1.80008802 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.79909893 |
35 | MP0010155_abnormal_intestine_physiology | 1.76853857 |
36 | MP0003448_altered_tumor_morphology | 1.76625364 |
37 | MP0008469_abnormal_protein_level | 1.69376120 |
38 | * MP0000716_abnormal_immune_system | 1.69006907 |
39 | MP0002254_reproductive_system_inflammat | 1.63667619 |
40 | MP0001346_abnormal_lacrimal_gland | 1.63341457 |
41 | MP0002166_altered_tumor_susceptibility | 1.61557628 |
42 | MP0003806_abnormal_nucleotide_metabolis | 1.61349432 |
43 | MP0002398_abnormal_bone_marrow | 1.60377753 |
44 | MP0008004_abnormal_stomach_pH | 1.58062484 |
45 | MP0002277_abnormal_respiratory_mucosa | 1.50723260 |
46 | MP0005464_abnormal_platelet_physiology | 1.50403882 |
47 | MP0005058_abnormal_lysosome_morphology | 1.49243820 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.44430434 |
49 | MP0004782_abnormal_surfactant_physiolog | 1.41467775 |
50 | MP0000569_abnormal_digit_pigmentation | 1.39309126 |
51 | MP0006054_spinal_hemorrhage | 1.36658329 |
52 | MP0009278_abnormal_bone_marrow | 1.29215896 |
53 | MP0001545_abnormal_hematopoietic_system | 1.29197142 |
54 | MP0005397_hematopoietic_system_phenotyp | 1.29197142 |
55 | * MP0002429_abnormal_blood_cell | 1.27997610 |
56 | MP0003075_altered_response_to | 1.25283183 |
57 | MP0002998_abnormal_bone_remodeling | 1.24130607 |
58 | MP0000858_altered_metastatic_potential | 1.19601199 |
59 | MP0005167_abnormal_blood-brain_barrier | 1.18282084 |
60 | MP0003172_abnormal_lysosome_physiology | 1.14353847 |
61 | MP0000343_altered_response_to | 1.13227086 |
62 | * MP0000689_abnormal_spleen_morphology | 1.09299942 |
63 | MP0002722_abnormal_immune_system | 1.08235676 |
64 | MP0005379_endocrine/exocrine_gland_phen | 1.08051565 |
65 | MP0009763_increased_sensitivity_to | 1.00481778 |
66 | MP0003763_abnormal_thymus_physiology | 1.00156640 |
67 | MP0003186_abnormal_redox_activity | 0.98881904 |
68 | MP0003091_abnormal_cell_migration | 0.97924146 |
69 | MP0010307_abnormal_tumor_latency | 0.97085896 |
70 | MP0005165_increased_susceptibility_to | 0.92849106 |
71 | MP0005166_decreased_susceptibility_to | 0.92522564 |
72 | MP0005164_abnormal_response_to | 0.91876220 |
73 | MP0005076_abnormal_cell_differentiation | 0.87466853 |
74 | MP0001663_abnormal_digestive_system | 0.87317086 |
75 | MP0003191_abnormal_cellular_cholesterol | 0.87169007 |
76 | MP0000604_amyloidosis | 0.86030286 |
77 | MP0003656_abnormal_erythrocyte_physiolo | 0.85076960 |
78 | MP0005390_skeleton_phenotype | 0.84613544 |
79 | MP0008874_decreased_physiological_sensi | 0.82772483 |
80 | MP0003453_abnormal_keratinocyte_physiol | 0.76485305 |
81 | MP0004858_abnormal_nervous_system | 0.76013985 |
82 | MP0009840_abnormal_foam_cell | 0.75704020 |
83 | MP0001542_abnormal_bone_strength | 0.73340642 |
84 | MP0002876_abnormal_thyroid_physiology | 0.71346150 |
85 | MP0005647_abnormal_sex_gland | 0.70234668 |
86 | MP0000249_abnormal_blood_vessel | 0.69705506 |
87 | MP0002933_joint_inflammation | 0.67917070 |
88 | MP0010386_abnormal_urinary_bladder | 0.67670579 |
89 | MP0000371_diluted_coat_color | 0.65888782 |
90 | MP0001881_abnormal_mammary_gland | 0.61594787 |
91 | MP0004883_abnormal_blood_vessel | 0.61590479 |
92 | MP0002332_abnormal_exercise_endurance | 0.60795921 |
93 | MP0002693_abnormal_pancreas_physiology | 0.60319214 |
94 | MP0009765_abnormal_xenobiotic_induced | 0.59384696 |
95 | MP0003828_pulmonary_edema | 0.59087057 |
96 | MP0005535_abnormal_body_temperature | 0.58671152 |
97 | MP0000609_abnormal_liver_physiology | 0.58571751 |
98 | MP0005023_abnormal_wound_healing | 0.58553794 |
99 | MP0008260_abnormal_autophagy | 0.57980552 |
100 | MP0001873_stomach_inflammation | 0.57345310 |
101 | MP0000465_gastrointestinal_hemorrhage | 0.57117622 |
102 | MP0000920_abnormal_myelination | 0.56964533 |
103 | MP0005174_abnormal_tail_pigmentation | 0.56801375 |
104 | MP0000490_abnormal_crypts_of | 0.55953202 |
105 | MP0000015_abnormal_ear_pigmentation | 0.55594280 |
106 | MP0003566_abnormal_cell_adhesion | 0.54814558 |
107 | MP0003183_abnormal_peptide_metabolism | 0.54588022 |
108 | MP0000627_abnormal_mammary_gland | 0.54260823 |
109 | MP0000703_abnormal_thymus_morphology | 0.53808769 |
110 | MP0005266_abnormal_metabolism | 0.53720954 |
111 | MP0000767_abnormal_smooth_muscle | 0.53317801 |
112 | * MP0002136_abnormal_kidney_physiology | 0.52926018 |
113 | MP0002877_abnormal_melanocyte_morpholog | 0.52713872 |
114 | MP0003795_abnormal_bone_structure | 0.52594543 |
115 | MP0003690_abnormal_glial_cell | 0.51981669 |
116 | MP0005319_abnormal_enzyme/_coenzyme | 0.49392420 |
117 | MP0005381_digestive/alimentary_phenotyp | 0.48707512 |
118 | MP0001851_eye_inflammation | 0.48434036 |
119 | MP0004808_abnormal_hematopoietic_stem | 0.46369900 |
120 | MP0003646_muscle_fatigue | 0.44482964 |
121 | MP0005171_absent_coat_pigmentation | 0.44080531 |
122 | MP0003045_fibrosis | 0.43706241 |
123 | MP0001879_abnormal_lymphatic_vessel | 0.43310456 |
124 | MP0003195_calcinosis | 0.42550095 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 7.01142089 |
2 | Recurrent bacterial skin infections (HP:0005406) | 6.76608251 |
3 | Eczematoid dermatitis (HP:0000976) | 6.60260071 |
4 | Autoimmune thrombocytopenia (HP:0001973) | 5.97574720 |
5 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.55215339 |
6 | Mediastinal lymphadenopathy (HP:0100721) | 5.42598954 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.06184635 |
8 | Abnormality of macrophages (HP:0004311) | 4.84243453 |
9 | Vasculitis (HP:0002633) | 4.75204043 |
10 | Retrobulbar optic neuritis (HP:0100654) | 4.37210949 |
11 | Optic neuritis (HP:0100653) | 4.37210949 |
12 | Gastrointestinal infarctions (HP:0005244) | 4.31448362 |
13 | Recurrent skin infections (HP:0001581) | 4.21864727 |
14 | Orchitis (HP:0100796) | 4.16571278 |
15 | Basal ganglia calcification (HP:0002135) | 4.08571413 |
16 | Myositis (HP:0100614) | 4.05764797 |
17 | Stomatitis (HP:0010280) | 4.04613718 |
18 | Recurrent fungal infections (HP:0002841) | 4.02466608 |
19 | Gingivitis (HP:0000230) | 4.00099302 |
20 | Recurrent viral infections (HP:0004429) | 3.81057796 |
21 | Loss of speech (HP:0002371) | 3.72326235 |
22 | Dysostosis multiplex (HP:0000943) | 3.59531056 |
23 | * Increased IgM level (HP:0003496) | 3.58132722 |
24 | Chronic otitis media (HP:0000389) | 3.52579585 |
25 | Disinhibition (HP:0000734) | 3.49352271 |
26 | Tetraparesis (HP:0002273) | 3.47076210 |
27 | Systemic lupus erythematosus (HP:0002725) | 3.44846730 |
28 | Pulmonary infiltrates (HP:0002113) | 3.38952096 |
29 | Thick nail (HP:0001805) | 3.36658089 |
30 | Obstructive lung disease (HP:0006536) | 3.34296891 |
31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.34296891 |
32 | Periodontitis (HP:0000704) | 3.33518037 |
33 | Porencephaly (HP:0002132) | 3.18449493 |
34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16467775 |
35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16467775 |
36 | Interstitial pulmonary disease (HP:0006530) | 3.16143563 |
37 | Recurrent pneumonia (HP:0006532) | 3.15407758 |
38 | Autoimmune hemolytic anemia (HP:0001890) | 3.08392985 |
39 | Cellulitis (HP:0100658) | 2.99124423 |
40 | Mutism (HP:0002300) | 2.95724838 |
41 | Pustule (HP:0200039) | 2.94709991 |
42 | * Hypergammaglobulinemia (HP:0010702) | 2.94637314 |
43 | Prostate neoplasm (HP:0100787) | 2.92126165 |
44 | Nuclear cataract (HP:0100018) | 2.89333695 |
45 | Urticaria (HP:0001025) | 2.84365038 |
46 | Hemoptysis (HP:0002105) | 2.83126966 |
47 | Premature loss of primary teeth (HP:0006323) | 2.81901369 |
48 | Recurrent sinusitis (HP:0011108) | 2.80481013 |
49 | Recurrent lower respiratory tract infections (HP:0002783) | 2.80046736 |
50 | Meningitis (HP:0001287) | 2.80034705 |
51 | Vacuolated lymphocytes (HP:0001922) | 2.77799797 |
52 | Leukocytosis (HP:0001974) | 2.71746382 |
53 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70469893 |
54 | Eosinophilia (HP:0001880) | 2.69731425 |
55 | Arterial thrombosis (HP:0004420) | 2.69102239 |
56 | Abnormality of T cell number (HP:0011839) | 2.65211406 |
57 | Restrictive lung disease (HP:0002091) | 2.62245162 |
58 | Encephalitis (HP:0002383) | 2.61236866 |
59 | Recurrent bronchitis (HP:0002837) | 2.59535747 |
60 | Osteomyelitis (HP:0002754) | 2.59181446 |
61 | Agammaglobulinemia (HP:0004432) | 2.59152554 |
62 | Parakeratosis (HP:0001036) | 2.58263618 |
63 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.55733867 |
64 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.55733867 |
65 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.55733867 |
66 | Increased serum ferritin (HP:0003281) | 2.53551818 |
67 | Gingival bleeding (HP:0000225) | 2.52713094 |
68 | Increased IgE level (HP:0003212) | 2.51414694 |
69 | Hematochezia (HP:0002573) | 2.44532528 |
70 | Gastrointestinal stroma tumor (HP:0100723) | 2.44345028 |
71 | Chronic sinusitis (HP:0011109) | 2.44337604 |
72 | Keratoconjunctivitis (HP:0001096) | 2.43016778 |
73 | Mucopolysacchariduria (HP:0008155) | 2.42914721 |
74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42914721 |
75 | Keratoconjunctivitis sicca (HP:0001097) | 2.42903171 |
76 | Progressive neurologic deterioration (HP:0002344) | 2.39263739 |
77 | Joint swelling (HP:0001386) | 2.36220719 |
78 | * IgA deficiency (HP:0002720) | 2.35334383 |
79 | Vertebral compression fractures (HP:0002953) | 2.35081707 |
80 | Nasal polyposis (HP:0100582) | 2.34455129 |
81 | B lymphocytopenia (HP:0010976) | 2.32830033 |
82 | Abnormality of B cell number (HP:0010975) | 2.31428265 |
83 | Cleft eyelid (HP:0000625) | 2.31241834 |
84 | Apathy (HP:0000741) | 2.30264581 |
85 | Anorexia (HP:0002039) | 2.30169282 |
86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.29575684 |
87 | Arthralgia (HP:0002829) | 2.29011491 |
88 | Nausea (HP:0002018) | 2.28540697 |
89 | Polyneuropathy (HP:0001271) | 2.28305754 |
90 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28210581 |
91 | Osteolytic defects of the hand bones (HP:0009699) | 2.28210581 |
92 | Axonal loss (HP:0003447) | 2.26413560 |
93 | Granulocytopenia (HP:0001913) | 2.25727800 |
94 | Hepatosplenomegaly (HP:0001433) | 2.24310807 |
95 | Abnormality of T cell physiology (HP:0011840) | 2.20980260 |
96 | Colitis (HP:0002583) | 2.20773193 |
97 | Gangrene (HP:0100758) | 2.19871527 |
98 | Poor head control (HP:0002421) | 2.19702577 |
99 | Diminished motivation (HP:0000745) | 2.19015254 |
100 | Chest pain (HP:0100749) | 2.18436669 |
101 | Myocardial infarction (HP:0001658) | 2.18025896 |
102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.17570238 |
103 | Neurofibrillary tangles (HP:0002185) | 2.17188130 |
104 | Abnormality of the pericardium (HP:0001697) | 2.16290143 |
105 | Petechiae (HP:0000967) | 2.15881641 |
106 | Emphysema (HP:0002097) | 2.14152215 |
107 | IgM deficiency (HP:0002850) | 2.13136990 |
108 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12968006 |
109 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12968006 |
110 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12968006 |
111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12404002 |
112 | Abnormality of eosinophils (HP:0001879) | 2.11542359 |
113 | Increased cerebral lipofuscin (HP:0011813) | 2.10164591 |
114 | Bone pain (HP:0002653) | 2.10143104 |
115 | Complement deficiency (HP:0004431) | 2.09477974 |
116 | Amaurosis fugax (HP:0100576) | 2.09025583 |
117 | T lymphocytopenia (HP:0005403) | 2.08451139 |
118 | Skin ulcer (HP:0200042) | 2.08028086 |
119 | Abnormality of the nasal mucosa (HP:0000433) | 2.06359832 |
120 | Abnormality of T cells (HP:0002843) | 2.04359131 |
121 | Chronic diarrhea (HP:0002028) | 2.04132602 |
122 | Lymphopenia (HP:0001888) | 2.03922806 |
123 | Memory impairment (HP:0002354) | 2.02527277 |
124 | Hypertensive crisis (HP:0100735) | 2.02305534 |
125 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.00431804 |
126 | Prolonged neonatal jaundice (HP:0006579) | 1.96448052 |
127 | Progressive visual loss (HP:0000529) | 1.96337186 |
128 | Purpura (HP:0000979) | 1.95140933 |
129 | Sepsis (HP:0100806) | 1.92088862 |
130 | Abnormality of the pleura (HP:0002103) | 1.88635938 |
131 | Glomerulonephritis (HP:0000099) | 1.86532309 |
132 | Inflammation of the large intestine (HP:0002037) | 1.84654381 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 6.01838322 |
2 | TBK1 | 4.14481762 |
3 | PBK | 4.00141060 |
4 | RIPK4 | 3.74552062 |
5 | TYK2 | 3.61043486 |
6 | IRAK4 | 3.40199009 |
7 | IKBKE | 3.25835274 |
8 | JAK3 | 3.20162605 |
9 | IKBKB | 3.13838060 |
10 | BLK | 3.08555258 |
11 | IRAK3 | 2.82089487 |
12 | MAP3K13 | 2.76472496 |
13 | TAOK2 | 2.53843534 |
14 | PRPF4B | 2.51056951 |
15 | DDR2 | 2.46225490 |
16 | PIM2 | 2.40625870 |
17 | JAK1 | 2.25547452 |
18 | CHUK | 2.17717406 |
19 | BMPR2 | 1.97928800 |
20 | TXK | 1.81180543 |
21 | MST4 | 1.77122055 |
22 | MAP4K1 | 1.61837408 |
23 | KIT | 1.57196549 |
24 | SYK | 1.50441693 |
25 | CDC42BPA | 1.45220742 |
26 | MAP3K3 | 1.42519226 |
27 | SIK3 | 1.39053038 |
28 | TAOK1 | 1.30905744 |
29 | BCR | 1.25503828 |
30 | NEK9 | 1.24783252 |
31 | EIF2AK2 | 1.22534658 |
32 | TGFBR2 | 1.16612592 |
33 | CSK | 1.13562767 |
34 | ARAF | 1.13055403 |
35 | PIM1 | 1.09668612 |
36 | ZAP70 | 1.08831991 |
37 | MARK3 | 1.06608758 |
38 | RPS6KA4 | 1.03987147 |
39 | STK4 | 1.03364981 |
40 | MAP2K3 | 1.03045938 |
41 | IRAK1 | 1.01301795 |
42 | JAK2 | 1.00184023 |
43 | BMX | 0.99752901 |
44 | HCK | 0.98266425 |
45 | ABL2 | 0.97401972 |
46 | LYN | 0.95599158 |
47 | FGFR3 | 0.94841580 |
48 | ERN1 | 0.92230884 |
49 | FGFR4 | 0.91926662 |
50 | BTK | 0.91512483 |
51 | EPHB1 | 0.87887001 |
52 | LCK | 0.87746191 |
53 | ERBB3 | 0.84660207 |
54 | TAOK3 | 0.84458802 |
55 | MAP3K5 | 0.82894135 |
56 | IRAK2 | 0.82295199 |
57 | EPHA3 | 0.80966789 |
58 | TLK1 | 0.79883627 |
59 | MATK | 0.78093865 |
60 | CSF1R | 0.76019764 |
61 | PKN1 | 0.75320934 |
62 | TESK2 | 0.70217933 |
63 | NME2 | 0.69829662 |
64 | PRKCD | 0.65571357 |
65 | PRKCQ | 0.65428687 |
66 | YES1 | 0.64441487 |
67 | FGR | 0.63227673 |
68 | CLK1 | 0.62569812 |
69 | SMG1 | 0.58266642 |
70 | TRPM7 | 0.57862569 |
71 | ABL1 | 0.57516409 |
72 | SIK2 | 0.56403835 |
73 | INSRR | 0.56071160 |
74 | HIPK2 | 0.56051307 |
75 | TESK1 | 0.54553964 |
76 | BMPR1B | 0.54245990 |
77 | TEC | 0.51251382 |
78 | MAPK4 | 0.48599174 |
79 | STK3 | 0.48547154 |
80 | MAPKAPK2 | 0.48291599 |
81 | NUAK1 | 0.48018546 |
82 | EGFR | 0.47460988 |
83 | ADRBK2 | 0.42419767 |
84 | EIF2AK3 | 0.42017734 |
85 | KDR | 0.41821672 |
86 | PLK2 | 0.38420478 |
87 | TYRO3 | 0.38126806 |
88 | MST1R | 0.36938056 |
89 | DAPK3 | 0.36805922 |
90 | MAPK7 | 0.36259956 |
91 | NLK | 0.36233679 |
92 | CDK4 | 0.36160259 |
93 | MAP2K6 | 0.35064153 |
94 | PTK6 | 0.33199252 |
95 | MAP3K8 | 0.32272527 |
96 | ERBB4 | 0.30891249 |
97 | CDK6 | 0.30660499 |
98 | PDK1 | 0.29034234 |
99 | GRK7 | 0.28935847 |
100 | MAPK11 | 0.28231613 |
101 | FES | 0.28107630 |
102 | RPS6KA1 | 0.26767213 |
103 | MOS | 0.26500671 |
104 | RPS6KA5 | 0.26045156 |
105 | PLK4 | 0.23737626 |
106 | PRKCE | 0.23601808 |
107 | CCNB1 | 0.23458674 |
108 | LATS2 | 0.22466869 |
109 | MAP3K9 | 0.22311219 |
110 | MAP3K11 | 0.21921643 |
111 | ZAK | 0.21871235 |
112 | ACVR1B | 0.21437529 |
113 | RIPK1 | 0.18330602 |
114 | STK10 | 0.17981175 |
115 | PDGFRA | 0.17878114 |
116 | DYRK1B | 0.17317254 |
117 | SGK1 | 0.17277564 |
118 | INSR | 0.15722171 |
119 | FYN | 0.15329105 |
120 | IGF1R | 0.14948491 |
121 | BRAF | 0.14778151 |
122 | MAP3K1 | 0.14575348 |
123 | PAK4 | 0.14517486 |
124 | RPS6KA6 | 0.14065039 |
125 | SRC | 0.11410979 |
126 | STK24 | 0.11393879 |
127 | PIK3CG | 0.10944124 |
128 | PTK2B | 0.10879241 |
129 | LRRK2 | 0.10724640 |
130 | CDK12 | 0.10653284 |
131 | DAPK2 | 0.10377922 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.99746817 |
2 | * Allograft rejection_Homo sapiens_hsa05330 | 3.58047064 |
3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.33015888 |
4 | Leishmaniasis_Homo sapiens_hsa05140 | 3.19962491 |
5 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.06743018 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.05183580 |
7 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.89997563 |
8 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.82787987 |
9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.64636087 |
10 | Measles_Homo sapiens_hsa05162 | 2.52318763 |
11 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.40963302 |
12 | Legionellosis_Homo sapiens_hsa05134 | 2.39259016 |
13 | Influenza A_Homo sapiens_hsa05164 | 2.30778118 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.25572298 |
15 | Pertussis_Homo sapiens_hsa05133 | 2.23473337 |
16 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.19810132 |
17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16490358 |
18 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.16393708 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.10235479 |
20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.02030147 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.00352694 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.92786243 |
23 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62661833 |
24 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61326044 |
25 | * Malaria_Homo sapiens_hsa05144 | 1.60007756 |
26 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.58356116 |
27 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.52175950 |
28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51210023 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.48881636 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.48291369 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.47401466 |
32 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46618204 |
33 | Salmonella infection_Homo sapiens_hsa05132 | 1.42757595 |
34 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.41820796 |
35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34873217 |
36 | Shigellosis_Homo sapiens_hsa05131 | 1.24110718 |
37 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.18830499 |
38 | Phagosome_Homo sapiens_hsa04145 | 1.18220953 |
39 | Hepatitis C_Homo sapiens_hsa05160 | 1.16991533 |
40 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15067394 |
41 | Hepatitis B_Homo sapiens_hsa05161 | 1.13728368 |
42 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.11018389 |
43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00693444 |
44 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 0.99711923 |
45 | Lysosome_Homo sapiens_hsa04142 | 0.94841693 |
46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.91273538 |
47 | * Asthma_Homo sapiens_hsa05310 | 0.88242798 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87965935 |
49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80672412 |
50 | Amoebiasis_Homo sapiens_hsa05146 | 0.79599549 |
51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74989830 |
52 | Prion diseases_Homo sapiens_hsa05020 | 0.68860018 |
53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65281445 |
54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65125898 |
55 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65072639 |
56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62560518 |
57 | Proteasome_Homo sapiens_hsa03050 | 0.61087345 |
58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59224582 |
59 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59088325 |
60 | Bladder cancer_Homo sapiens_hsa05219 | 0.56964041 |
61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56396811 |
62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56222388 |
63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.56206340 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55808584 |
65 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52314070 |
66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51710818 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48708979 |
68 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48667122 |
69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.47554534 |
70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44120197 |
71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43588929 |
72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43535733 |
73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42759624 |
74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42169243 |
75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38417375 |
76 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38393368 |
77 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38193796 |
78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37837851 |
79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37505355 |
80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.34882667 |
81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31620416 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30041064 |
83 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29759592 |
84 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29503442 |
85 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.28557599 |
86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28503913 |
87 | Platelet activation_Homo sapiens_hsa04611 | 0.27961461 |
88 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27941085 |
89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23799223 |
90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.23749065 |
91 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.22051992 |
92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.20932585 |
93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.18174484 |
94 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.17581560 |
95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17187188 |
96 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.17087035 |
97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17006809 |
98 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16176256 |
99 | Mineral absorption_Homo sapiens_hsa04978 | 0.15966249 |
100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15810728 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.13843499 |
102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.13349703 |
103 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.11238094 |
104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.11237236 |
105 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10014293 |
106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.09556484 |
107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.07337487 |
108 | Prostate cancer_Homo sapiens_hsa05215 | 0.06739415 |
109 | Endocytosis_Homo sapiens_hsa04144 | 0.04376678 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03722028 |
111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.01911314 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.01507510 |
113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | -0.0217139 |
114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0096595 |
115 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.0063343 |